Sugammadex

Product NDC
83301-0078
Requested package NDC
83301-0078-2
11-digit product format
833010078
Labeler code
83301
Product ID
83301-0078_7e2e6873-a8ed-4f4f-836f-30c7ccadd92c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
SUGAMMADEX SODIUM
Dosage form
INJECTION
Route
INTRAVENOUS
Labeler
Mullan Pharmaceutical Inc.
Application
ANDA215701
Marketing category
ANDA
Marketing start
2026-11-02
Substance
SUGAMMADEX SODIUM
Active strength
500 mg/5mL
Pharmacologic classes
gamma-Cyclodextrins [CS]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A215701-001SUGAMMADEX SODIUMSUGAMMADEX SODIUMEQ 200MG BASE/2ML (EQ 100MG BASE/ML)SOLUTION / INTRAVENOUSAP2026-10-06
A215701-002SUGAMMADEX SODIUMSUGAMMADEX SODIUMEQ 500MG BASE/5ML (EQ 100MG BASE/ML)SOLUTION / INTRAVENOUSAP2026-10-06

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A215701-001AP
A215701-002AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A215701-001SUGAMMADEX SODIUMEQ 200MG BASE/2ML (EQ 100MG BASE/ML)SOLUTION / INTRAVENOUSAP2026-10-06d4dbc9d85df4…
2026-11-14 07:37:172026-10A215701-002SUGAMMADEX SODIUMEQ 500MG BASE/5ML (EQ 100MG BASE/ML)SOLUTION / INTRAVENOUSAP2026-10-06d4dbc9d85df4…
2026-10-15 13:18:302026-09A215701-001SUGAMMADEX SODIUMEQ 200MG BASE/2ML (EQ 100MG BASE/ML)SOLUTION / INTRAVENOUSAP2026-10-06c2088c7a36db…
2026-10-15 13:18:302026-09A215701-002SUGAMMADEX SODIUMEQ 500MG BASE/5ML (EQ 100MG BASE/ML)SOLUTION / INTRAVENOUSAP2026-10-06c2088c7a36db…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A215701-001AP1d4dbc9d85df4…
2026-11-14 07:37:172026-10A215701-002AP1d4dbc9d85df4…
2026-10-15 13:18:302026-09A215701-001AP1c2088c7a36db…
2026-10-15 13:18:302026-09A215701-002AP1c2088c7a36db…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Sugammadex
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
SUGAMMADEX SODIUM500 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
ERJ6X2MXV7Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1726992Internal RxNorm lookup
1727000Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
5373abf1-c6ef-4295-9b2e-b07964b2fe37Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SugammadexSUGAMMADEX SODIUMMullan Pharmaceutical Inc.5373abf1-c6ef-4295-9b2e-b07964b2fe372026-11-02Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215701
application number: ANDA215701
ndc (package): 83301-0078-2
ndc (product): 83301-0078
ndc11 (package): 83301007802
SugammadexSUGAMMADEXShandong New Time Pharmaceutical Co., Ltd.56400560-a2df-4126-b424-9e4b91e53a8b2025-03-24Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215701
application number: ANDA215701

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
83301-0078-28330100780210 VIAL, SINGLE-DOSE in 1 CARTON (83301-0078-2) / 5 mL in 1 VIAL, SINGLE-DOSE (83301-0078-1) 2026-11-02NoNoCurrent